Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
ED.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
ED.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
ED.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
ED.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
ED.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
ED.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
ED.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ED.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
ED.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
ED.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
ED.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
ED.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ED.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
ED.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
ED.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ED.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ED.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
ED.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
ED.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
ED.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
ED.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
ED.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ED.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BU.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BU.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BU.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BU.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-4270.22Thailand
BU.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BU.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BU.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BU.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BU.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BU.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BU.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BU.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BU.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BU.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BU.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BU.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BU.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BU.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BU.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BU.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BU.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used